Medical Cannabis for Glaucoma — Switzerland 2026
THC lowers intraocular pressure — briefly. For daily glaucoma therapy it's barely practical. We honestly say where cannabis helps and where standard drops stay unbeatable.
THC lowers intraocular pressure by 25–30 % — but only for 3–4 h. That would need 6–8 daily doses, unrealistic. First line remains prostaglandins (latanoprost). Cannabis useful as add-on for pain, anxiety or intolerance. CBD does not lower pressure and can even raise it slightly. CannabisClub members: 50 CHF flat instead of 190.
What the studies show
Hepler 1971 & Merritt 1980: THC lowers intraocular pressure by 25–30 %, but only 3–4 h.
American Academy of Ophthalmology 2019: no recommendation for cannabis first-line — continuous dosing practically impossible.
When cannabis still makes sense
In comorbid pain, migraine or anxiety — the underlying pathology stays on medical therapy, cannabis reduces symptoms.
On intolerance of prostaglandins or beta-blockers, as add-on with ophthalmology approval.
Save as a CannabisClub member
External consult 190 CHF, member 50 CHF flat. Important: primary glaucoma therapy stays with the ophthalmologist — cannabis is adjunct.
Registration is free. Become a member now.
FAQ
Does cannabis replace my eye drops?
No. Latanoprost, timolol & co are unbeatable in dosability and duration. Cannabis acts too briefly for meaningful monotherapy.
What does membership save?
50 CHF instead of 190 CHF per consult. Quarterly follow-up: 560 CHF/year. Registration free.
Does insurance cover cannabis for glaucoma?
Practically never as monotherapy. In comorbid pain, possible within an Art. 71a HIO agreement.
Cannabis for Glaucoma — Facts, Limits & Prescription Switzerland 2026 (Members 50 CHF)